123 related articles for article (PubMed ID: 21743148)
1. [Inhibitory effect of GnRHII and GnRH Ia on the stromal cell proliferation from endometriosis patients].
Huang F; Wang H; Wu M; Yin T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):554-8. PubMed ID: 21743148
[TBL] [Abstract][Full Text] [Related]
2. Effect of GnRH II and GnRH I on secretion of VEGF by eutopic and ectopic endometrial stromal cells of endometriosis patients.
Huang F; Liu Q; Wang H; Zou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):409-18. PubMed ID: 20543462
[TBL] [Abstract][Full Text] [Related]
3. In vitro apoptosis effects of GnRHII on endometrial stromal cells from patients with endometriosis.
Huang F; Zou Y; Wang H; Cao J; Yin T
Int J Clin Exp Pathol; 2013; 6(8):1603-9. PubMed ID: 23926453
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells.
Taniguchi F; Higaki H; Azuma Y; Deura I; Iwabe T; Harada T; Terakawa N
Gynecol Obstet Invest; 2013; 75(1):9-15. PubMed ID: 23147672
[TBL] [Abstract][Full Text] [Related]
5. [Effect of GnRH-II on VEGF secreted by stromal cells from endometrium of endometriosis].
Liu Q; Huang F; Wang H; Zou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 34(9):926-32. PubMed ID: 19779269
[TBL] [Abstract][Full Text] [Related]
6. Effect of GnRH-II on the ESC proliferation, apoptosis and VEGF secretion in patients with endometriosis in vitro.
Huang F; Wang H; Zou Y; Liu Q; Cao J; Yin T
Int J Clin Exp Pathol; 2013; 6(11):2487-96. PubMed ID: 24228111
[TBL] [Abstract][Full Text] [Related]
7. [Influence of gonadotropin releasing hormone agonist on the expression of mRNA of nerve growth factor and its receptors in eutopic endometrial stromal cells].
Li XY; Leng JH; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):440-4. PubMed ID: 22932111
[TBL] [Abstract][Full Text] [Related]
8. GnRH II as a possible cytostatic regulator in the development of endometriosis.
Morimoto C; Osuga Y; Yano T; Takemura Y; Harada M; Hirata T; Hirota Y; Yoshino O; Koga K; Kugu K; Taketani Y
Hum Reprod; 2005 Nov; 20(11):3212-8. PubMed ID: 16037111
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
Kim YA; Kim MR; Lee JH; Kim JY; Hwang KJ; Kim HS; Lee ES
Gynecol Obstet Invest; 2009; 68(2):73-81. PubMed ID: 19401614
[TBL] [Abstract][Full Text] [Related]
10. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis.
Tesone M; Bilotas M; Barañao RI; Meresman G
Gynecol Obstet Invest; 2008; 66 Suppl 1():10-8. PubMed ID: 18936547
[TBL] [Abstract][Full Text] [Related]
11. Effect of GnRHa on apoptosis and release of VEGF in endometrial cell cultures from patients with adenomyosis.
Xiao-xia W; Jia-li K; Xue-fei S; Jia Y; Ling-hong D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):72-3. PubMed ID: 22512052
[TBL] [Abstract][Full Text] [Related]
12. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
[TBL] [Abstract][Full Text] [Related]
13. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium.
Gomes MK; Rosa-e-Silva JC; Garcia SB; de Sá Rosa-e-Silva AC; Turatti A; Vieira CS; Ferriani RA
Hum Reprod; 2009 Nov; 24(11):2736-45. PubMed ID: 19661125
[TBL] [Abstract][Full Text] [Related]
14. Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response.
Novembri R; Carrarelli P; Toti P; Rocha AL; Borges LE; Reis FM; Piomboni P; Florio P; Petraglia F
Mol Hum Reprod; 2011 Sep; 17(9):587-93. PubMed ID: 21454316
[TBL] [Abstract][Full Text] [Related]
15. [Influences of gonadotropin releasing hormone agonist treatment on nitric oxide synthase expression in women with endometriosis and infertility].
Wang JH; Zhou FZ; Dong MY; Yuan L
Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):383-7. PubMed ID: 16008888
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the motility of human decidual endometrial stromal cells: possible effect on embryo implantation and pregnancy.
Wu HM; Huang HY; Lee CL; Soong YK; Leung PC; Wang HS
Biol Reprod; 2015 Apr; 92(4):98. PubMed ID: 25761596
[TBL] [Abstract][Full Text] [Related]
17. Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility.
Wang J; Zhou F; Dong M; Wu R; Qian Y
Fertil Steril; 2006 Apr; 85(4):1037-44. PubMed ID: 16580392
[TBL] [Abstract][Full Text] [Related]
18. Ectopic, autologous eutopic and normal endometrial stromal cells have altered expression and chemotactic activity of RANTES.
Fang CL; Han SP; Fu SL; Wang W; Kong N; Wang XL
Eur J Obstet Gynecol Reprod Biol; 2009 Mar; 143(1):55-60. PubMed ID: 19157676
[TBL] [Abstract][Full Text] [Related]
19. Lower antigenecity of long-term in vitro cultured eutopic endometrial stromal cells from endometriotic patients: a possible evidence of genetic disorders in endometriosis.
Tanaka T; Umesaki N; Ogita S
Osaka City Med J; 1998 Jun; 44(1):97-104. PubMed ID: 9834622
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells.
Zhao LJ; Liu N; Li XP; Wang JL; Wei LH
Chin Med J (Engl); 2010 May; 123(9):1170-5. PubMed ID: 20529558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
